| Johnson & Johnson's 3 Major Strengths 2:30pm / MotleyFool.com | Top 40 Upcoming Earnings Releases Apr 11 / Benzinga |
| If This Biotech Drops Much Further I'm Going to Buy It! 1:05pm / MotleyFool.com | Google Honors Chemist Percy Julian & His Contributions Apr 11 / Benzinga |
| Will Merck & Co. Inc Unseat Biotech's Hottest Drug? 9:31am / MotleyFool.com | JPMorgan's Earnings Disaster Drops the Dow 100 Points Apr 11 / MotleyFool.com |
| 2 Reasons Why Merck & Co. Is Crushing the Dow Apr 16 / MotleyFool.com | 3 Drugs Stocks Driving The Industry Higher Apr 11 / TheStreet.com |
| Gilead Sciences, Inc. Feeling Sovaldi Pressure From All Sides Apr 16 / MotleyFool.com | The Four Types of Growth Stocks Apr 11 / TheStreet.com |
| Could This Small-Cap Biotech's Experimental Diabetes Drug Be a Game Changer? Apr 16 / MotleyFool.com | Dow 30 Stock Roundup: Pfizer Drug Trial Dents, P&G Ups Dividend - Analyst Blog Apr 11 / Zacks.com |
| Jim Cramer's Top Stock Picks: WFM SBUX MRK STZ Apr 16 / TheStreet.com | Jim Cramer's Mad Dash: HRB GILD Apr 11 / TheStreet.com |
| How Much Has Merck Shaken Up the Hepatitis C Race? Apr 15 / MotleyFool.com | Merck Shouts "Me, Too!" But Will It Matter? Apr 11 / MotleyFool.com |
| Eli Lilly/ Boehringer Drug Under FDA Review - Analyst Blog Apr 15 / Zacks.com | US Stock Futures Slip Ahead Of Consumer Sentiment Report Apr 11 / Benzinga |
| FDA Nod for Merck's Grastek - Analyst Blog Apr 15 / Zacks.com | Merck Up on Encouraging HCV Data - Analyst Blog Apr 10 / Zacks.com |
| Leaders Of The Pharmaceutical Pack Apr 15 / StockTwits | May 30th Options Now Available For Merck (MRK) Apr 10 / TheStreet.com |
| Does Pfizer Offer Good Value? Apr 15 / MotleyFool.com | Dow Today: Merck (MRK) Leads The Day Higher, Chevron (CVX) Lags Apr 10 / TheStreet.com |
| This Forgotten Pharma Could Be a Hit for Your Portfolio Apr 15 / MotleyFool.com | Why Merck (MRK) Stock Is Higher This Morning Apr 10 / TheStreet.com |
| 3 Health Care Stocks Bucking the S&P Downtrend Apr 15 / MotleyFool.com | US Stock Futures Edge Lower Ahead Of Jobless Claims Data Apr 10 / Benzinga |
| Can Merck & Co. Inc. and Bristol-Myers Squibb Co. Dethrone Gilead Sciences Inc. for H... Apr 15 / MotleyFool.com | Today's Pre-Market Trading Very Positive For Merck (MRK) Apr 10 / TheStreet.com |
| Amgen's Conundrum Apr 14 / MotleyFool.com | Today's Biotech Stocks to Watch: Bristol-Myers Squibb, Gilead Sciences and Merck & Co... Apr 10 / MotleyFool.com |
| Hard-to-Cure Patients May Benefit from Merck's HCV Drug - Analyst Blog Apr 14 / Zacks.com | Why the Dow Jones Jumped 180 Points Today Apr 09 / MotleyFool.com |
| Market Wrap For April 14: Markets Surge on Positive Retail Data, Citi Earnings Apr 14 / Benzinga | Merck Moves the Dow and Facebook Pops as Earnings Season Gets Started Apr 09 / MotleyFool.com |
| Markets Falling? Get Your Defense Ready Apr 14 / Benzinga | EPO Upholds Alnylam's McSwiggen Patent - Analyst Blog Apr 08 / Zacks.com |
| Dow Today: International Business Machines (IBM) Leads The Day Higher, Merck (MRK) La... Apr 14 / TheStreet.com | Update on Merck's MK-3475 - Analyst Blog Apr 08 / Zacks.com |
| 3 Stocks Reiterated As A Buy: MDLZ, MRK, MCD Apr 14 / TheStreet.com | Merck Launches Hail Mary Lung Cancer Trial Apr 08 / MotleyFool.com |
| Is This the Answer to Expensive Hepatitis-C Cures? Apr 14 / MotleyFool.com | Takeda and Eli Lilly fall foul of jury in Actos trial Apr 08 / FT.com |
| Johnson & Johnson Earnings: Will Tuesday Bring More Good News for J&J? Apr 14 / MotleyFool.com | Takeda: a fine mess Apr 08 / FT.com |
| One Put, One Call Option To Know About For Merck & Co. Apr 14 / TheStreet.com | The Biggest Biotech Clinical Wins of the Week Apr 08 / MotleyFool.com |
| No Legwork Mondays b Merck And Vioxx Apr 14 / Benzinga | Can J&J's Pharma Segment Deliver Meaningful Growth? Apr 07 / MotleyFool.com |
+0.21 / +0.37%
-0.21 / -0.37%